@vvsmider
Biomedical researcher, antibody investigator (especially cow antibodies 🐮, which are the best), drug discoverer, entrepreneur 🇺🇸 🇺🇦 Founder and President at Applied Biomedical Science Institute: https://absinstitute.org
Svetlana Mojsov’s research paved the way for Ozempic, but she had to fight for her seat at the table. The Matilda Effect strikes again! 😤
This #WomensHistoryMonth, we begin by honoring the chemist who identified the active GLP-1 hormone.
It’s high time we credit the women who change the world. 🧪✨
And the science really isn’t “intriguing” at all…
This happens in science all the time- a little nugget of interesting data, filed away, that can re-emerge later in another context.
“it is time, finally and forever, to get rid of for-profit scientific publishers.”
Interesting story (and beautiful graphic) from Undark about how long NIH institute directors stay (and should stay) in their positions.
undark.org/2026/03/04/t...
“it is time, finally and forever, to get rid of for-profit scientific publishers.”
An announcement that the Senate voted to reauthroize the SBIR/STTR program.
The Senate has (finally) voted to reauthorize the small business SBIR/STTR program.
Not reauthorized yet, but this was likely the biggest hurdle.
This is a nice contrast to all the awful behavior confirmed through the Epstein files. Proud of @jenlucpiquant.bsky.social & @seanmcarroll.bsky.social for picking up on the sexism & charlatanism right away.
The mass psychosis over Ivermectin as a "cure all" miracle drug did not end w COVID. It's being embraced as a cure for cancer in right wing circles.
If you have scabies or a parasitic worm infection it ivermectin helps.
It is NOT effective chemotherapy for any cancer!
www.npr.org/2026/03/02/n...
Just had a meeting with another colleague who is leaving the United States for Canada because of the political and science climate here.
This is just devastating for science in America, but I totally understand.
Some shit is about to go down with NIH study sections, friends. Keep your eyes peeled for change that may affect your grant submissions.
bsky.app/profile/tiva...
Science and Engineering is the basis of modern civilization, but particularly those studies into fundamental things. It is a foundational building block from which most wealth eventually derives. When we sacrifice it, we sacrifice much of our future.
Ultra-sensitive CAR T cells eliminate hard-to-treat tumours in mice
A proof-of-concept study opens up an avenue for treating solid tumours that express low levels of a target antigen.
www.nature.com/artic...
1/3
Given that clonal biofilms of single bacterial species rapidly diversify into niche specialists, how do biofilms of multiple species evolve?
A 🧵 featuring new collaborative pubs:
1. www.biorxiv.org/content/10.6...
2. www.nature.com/articles/s41...
Ohh.... #biology #lego
That's right. Worse than Pointless
www.nytimes.com/2026/02/23/o...
So I’d imagine that I’m not the only one looking into switching my (low level) paid account from open.ai to Anthropic. Any thoughts about which performs better for your average academic scientist?
Every now and then I read a paper that opens my eyes to see an aspect of biology in a new way. This paper blew my mind - TLR7/8 have agonist sites to bind viral RNA, and antagonist sites to bind endogenous RNA degrad. products, enabling self/nonself discrimination: www.nature.com/articles/s41...
Rare disease day. I have chordoma, a one in a million cancer. 300 new cases a year. My husband died of neuroendocrine cancer, 10,000 new cases a year.
i note the steep cuts to the National Cancer Institute budget.
Very sad news. David Botstein made enormous contributions to molecular biology & genetics. I first met him in a grad school interview. I learned something from him each of the few times I saw him since. Indelible personality. Here he is giving a keynote at the 2015 UCSD Genetics Retreat.
Today, 1 in 10 Americans lives with a rare disease. Most of the 7,000+ identified worldwide still have no approved treatment.
Last year, @scripps.edu added its 18th FDA-approved medicine for one of these conditions—advancing options for patients with few alternatives. #RareDiseaseDay
A 1 y/o yellow Labrador retriever
Another Maisie - 1 y/o yellow lab
Bday last week
Today is #RareDiseaseDay
Through EB Research Partnership, families, scientists, and supporters are pushing research forward, pioneering progress in EB and helping reshape what’s possible for rare diseases.
It’s not a matter of if.
It’s a matter of time.
🦋 Learn more: ebresearch.org
These “cloaked” or “masked” antibody-based drugs are a clever way to reduce side effects. They are activated in the tumor but inert in the blood, sort of like a pro-drug. More positive results for these types of molecules for prostate #cancer.
www.icr.ac.uk/about-us/icr...
Hi Ian, we're so pleased that your cancer has been in remission for such a long time.
Hopefully you're interested in our article about the trial ⤵️
www.icr.ac.uk/about-us/icr...
Bear with me if you can as I attempt to use HPV vaccines to demonstrate why many can’t see the danger of RFK Jr.
TLDR: Disease prevention takes time and discipline. Not discipline of an individual, but the ability to invest in public health when the benefits may not be immediately clear.
Federal funding for US biomedical research is moribund.
Since October 1 2025, NIH is -80% in new grants and -70% in values (total dollars).
Labs are closing down and researchers are leaving science.
To what end?
We just interviewed Dr. Jay Bhattacharya on his vision for NIH, his new job at the CDC, on funding, on DEI and more. Available now: podcasts.apple.com/us/podcast/w...
